Additionally, a microRNA, miR-18a has been implicated in diabetes- breast cancer crosstalk and it reportedly target HIF1-α [181, 182], and YC-1 is a specific HIF1-α signaling inhibitor by blocking HIF1-α synthesis [183]. Here, HIF1A is linked to diabetes mellitus.